MSD Appoints Dina Mosallem as Pharma Business Unit Director

MSD, a leading global research-intensive biopharmaceutical company has appointed Dina Mosallem as Business Unit Director, Pharma – Gulf, Libya & Egypt, marking a significant expansion of her leadership responsibilities after more than 14 years of distinguished service with the global biopharmaceutical company.

The appointment marks the next step in Dina Mosallem's exceptional career trajectory within MSD, consistently showing excellence in commercial leadership, strategic marketing, oncology, portfolio management and regional business development. She has directed teams in various therapeutic areas and healthcare markets, making her a trusted and knowledgeable pharmaceutical leader for sustainable growth and change.

She collaborate closely with commercial, medical, market access, and cross-functional teams to further enhance the performance of the marketplace, drive portfolio growth, and advance patient-focused healthcare programs.

Key Highlights

• Wider leadership of the pharmaceutical business in the Gulf, Libya and Egypt.
• Has more than a decade of progressive commercial leadership experience at MSD.
• Robust background in oncology, marketing, portfolio and business development.

Dina has steadily carved out several influential roles in her career at MSD. Prior to this she was the GCC Marketing Director – Pharmaceuticals, GCC Marketing Lead – Pharmaceuticals and Associate Director – Strategy Realization Officer GCC on high impact projects delivering on commercial excellence, strategic planning, portfolio optimisation and organisational change. She has helped shape business strategy and market opportunities to the company's commercial success in the GCC, and has applied her expertise to the analysis and implementation of market data.

Prior to this, Dina was the Oncology Brand Manager – Gulf at MSD, where she managed the company's oncology portfolio and directed the development of one of the most important therapeutic areas in the Company's portfolio. Her expertise in oncology markets, physician engagement and brand strategy allowed her to make an impact on advancing patient access to novel cancer treatments.

Dina ‘s career with MSD started in Kuwait as a Professional Sales Representative – Diabetes Line, where she developed a solid foundation in the pharmaceutical sales and customer engagement field. She became a Senior Professional Sales Representative, then evolved into a marketing and commercial leader, gradually expanding her regional role. Her career path demonstrates her skills in driving business performance consistently, creating high-performing teams and promoting leadership and collaboration in complex healthcare settings.

In a letter about her appointment, Dina Mosallem stated that she is excited to serve in this new leadership position and build on her existing team of talented colleagues in improving patient access, fostering innovation, and enhancing the impact in the Gulf, Libya, and Egypt.

“Dina brings significant commercial experience, strategic thinking and leadership, making her uniquely qualified to lead our pharmaceutical business in these vital markets and remain a value provider for patients and healthcare systems,” added a senior MSD regional leader.

Dina Mosallem has proven knowledge and experience in commercial strategy, market access, portfolio management, oncology, strategic marketing and cross-market execution and will be best equipped to manage MSD's pharmaceutical business in the Gulf, Libya and Egypt. Her appointment reflects her exceptional leadership progression, and trust in her leadership skills to support business growth within the region, foster regional partnerships, and continue to lead the way in patient-centred healthcare within some of the company's most strategic markets.